Flatley Discovery Lab LLC
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 2009-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
9
Active:0
Completed:8
Trial Phases
1 Phases
Phase 1:9
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)β’ Click on a phase to view related trials
Phase 1
9 (100.0%)A DDI Study of FDL169 and FDL176 in Healthy Subjects
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Flatley Discovery Lab LLC
- Target Recruit Count
- 78
- Registration Number
- NCT03756922
- Locations
- π¬π§
Celerion GB Ltd, Belfast, United Kingdom
A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects
- First Posted Date
- 2018-05-16
- Last Posted Date
- 2018-11-02
- Lead Sponsor
- Flatley Discovery Lab LLC
- Target Recruit Count
- 11
- Registration Number
- NCT03527095
- Locations
- π¬π§
Quotient Sciences, Ruddington, Nottingham, United Kingdom
A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy Subjects
Phase 1
Completed
- Conditions
- Cystic Fibrosis
- Interventions
- Drug: FDL176 & FDL169 coadministration
- First Posted Date
- 2018-05-04
- Last Posted Date
- 2018-11-02
- Lead Sponsor
- Flatley Discovery Lab LLC
- Target Recruit Count
- 16
- Registration Number
- NCT03516331
- Locations
- π¬π§
Quotient Sciences, Nottingham, Ruddington, United Kingdom
An Phase 1 Study to Evaluate the Pharmacokinetic (PK) Profile of FDL169 New Formulations in Healthy Subjects
- First Posted Date
- 2018-02-06
- Last Posted Date
- 2018-11-02
- Lead Sponsor
- Flatley Discovery Lab LLC
- Target Recruit Count
- 11
- Registration Number
- NCT03424252
- Locations
- π¬π§
Quotient Sciences, Nottingham, United Kingdom
A Study to Assess the Safety, Tolerability and PK Profile of FDL176 in Healthy and CF Participants
- First Posted Date
- 2017-06-02
- Last Posted Date
- 2018-09-06
- Lead Sponsor
- Flatley Discovery Lab LLC
- Target Recruit Count
- 109
- Registration Number
- NCT03173573
- Locations
- π¦πΊ
Wayne Hooper Clinic Clive Berghofer Cancer research Center, Herston, Queenland, Australia
π¦πΊMater Hospital, South Brisbane, Queensland, Australia
π¦πΊLinear Clinical Research, Perth, Western Australia, Australia
- Prev
- 1
- 2
- Next
News
No news found